Aeolus Pharmaceuticals Inc (AOLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 12-2004 | 09-2004 | 06-2004 | 03-2004 | 12-2003 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,957 | -17,167 | -15,119 | -4,651 | -2,343 |
| Depreciation Amortization | 3 | 25 | 23 | 20 | 18 |
| Accounts receivable | 53 | -131 | N/A | N/A | N/A |
| Other Working Capital | -431 | 651 | 481 | 642 | 638 |
| Other Operating Activity | -2 | 7,981 | 7,660 | 267 | 218 |
| Operating Cash Flow | $-2,334 | $-8,641 | $-6,955 | $-3,722 | $-1,469 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 6,000 | 6,000 | 3,500 | 1,000 |
| Common Stock Issued | N/A | 9,436 | 9,424 | 2 | N/A |
| Financing Cash Flow | $N/A | $15,436 | $15,424 | $3,502 | $1,000 |
| Beginning Cash Position | 7,381 | 586 | 586 | 586 | 586 |
| End Cash Position | 5,047 | 7,381 | 9,055 | 366 | 117 |
| Net Cash Flow | $-2,334 | $6,795 | $8,469 | $-220 | $-469 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,334 | -8,641 | -6,955 | -3,722 | -1,469 |
| Free Cash Flow | -2,334 | -8,641 | -6,955 | -3,722 | -1,469 |